Industrial

Analysis by James Mawson, founder, Global Corporate Venturing and co-author of Transformative Innovation (with Christine Gulbranson)

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Legend Capital was among the investors in the synthetic biology-derived materials producer’s fourth round, which helped lift its total funding to over $100m.

SAIC Motor’s Hengxu Capital helped allosteric drug developer Nutshell Therapeutics close a $40m round while cancer therapy developer Impact Therapeutics secured series D1 funding.

GV returned for a multimillion dollar round raised by the clinical data software provider, which is part of a space of much interest to corporate investors.

Lunar expanded its series D round to $307m while RefleXion Medical raised $80m and Silent Eight raked in $40m.

SATT Aquitaine has signed up INRAE and its tech transfer arm for a five-year agreement to help commercialise its research.

GV and Animoca Brands helped earphone developer Nothing secure $70m while Cialfo bumped its Seek-backed series B round up to $60m.

ArcelorMittal, Mitsui, Novo, Siemens and Petronas are in line to exit the carbon recycling technology provider, which is set for a Nasdaq listing.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The corporate venturing industry is pushing towards a 50:50 split in senior investor roles.